PUMPING IRONY: Don’t Just Sit There, Do Something!
Sitting may be the new smoking, but recent research suggests that what you happen to be doing while parked in a chair — or on the couch — may mitigate its effect on your aging brain.
The latest revelations from a leader in the antiaging industry promise a treatment that could dial back the years, perhaps extending our lifespans indefinitely. But is the goal a longer life or something even more elusive?
While I only occasionally wonder whether Parkinson’s awaits me somewhere down the road, recent research provides some calming evidence that lifestyle changes may help keep the disease at bay.
An 18-month congressional investigation turned up plenty of dirt on the FDA’s dealings with Biogen during the agency’s controversial approval of the company’s Alzheimer’s drug, but its recommendations suggest the status quo will likely remain unchanged.
Growing old without the support of a spouse, children, or siblings can present daunting health challenges, but some who choose that path find it to be more blissful than you might imagine.
As Big Pharma’s latest Alzheimer’s drug faces renewed skepticism, a new study suggests that avoiding ultraprocessed food may be a more promising approach to maintaining healthy cognitive function as we age.
As the most recent — and virulent — of COVID variants spreads across the country, U.S. seniors have mostly ignored the available boosters. Is it time to increase our vigilance against a pandemic that refuses to retreat?
Just as cheaper over-the-counter hearing aids finally become widely available, researchers are trumpeting new approaches to hearing loss that may render those devices unnecessary.
PUMPING IRONY: When Screening Isn’t the Magic Bullet We Thought
A landmark study suggests that colonoscopies do not reduce the risk of cancer — or mortality — nearly as much as advertised. That’s welcome news for the millions of seniors who, like me, stubbornly avoid the procedure.
The latest miracle cure for Alzheimer’s is likely to receive accelerated approval from the FDA, which benefits as much from the cash that accompanies these requests as Big Pharma does from the agency’s lax standards.
Arthritic knees often send seniors looking for various surgical solutions, even as recent research — and personal experience — suggests the most reliable remedy may simply involve moving those troublesome joints more frequently.
While the Federal Trade Commission works to tighten regulations on the funeral industry, which often uses obscure pricing policies to prey on grief-stricken mourners, seniors like me need to start thinking more seriously about how we want to be laid to rest.
Physical activity has long been shown to improve cognitive function, but a new study suggests we may be able to modify our workouts to boost specific types of memory.
All the time we spend staring at screens could be shortening our lifespan, according to a new study. We do have options, though returning to the typewriter is not one of them.
I’ve discovered plenty of good reasons for postponing retirement and continuing to pursue purposeful work, but a new study suggests I may have overlooked an important one: It could help prevent a stroke.
The Inflation Reduction Act will make some prescription drugs much more affordable for strapped Medicare beneficiaries. But will it deepen our dependence on Big Pharma?